Tandem Diabetes Care Q3 EPS $(0.10) Beats $(0.25) Estimate, Sales $283.690M Beat $265.922M Estimate

Benzinga · 14h ago
Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.25) by 60 percent. This is a 67.74 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $283.690 million which beat the analyst consensus estimate of $265.922 million by 6.68 percent. This is a 13.82 percent increase over sales of $249.253 million the same period last year.